Cargando…
Rapid Quantification of SARS-CoV-2-Neutralizing Antibodies Using Propagation-Defective Vesicular Stomatitis Virus Pseudotypes
Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2, a new member of the genus Betacoronavirus, is a pandemic virus, which has caused numerous fatalities, particularly in the elderly and persons with underlying morbidities. At present, there are no approved vaccines nor antiviral therap...
Autores principales: | Zettl, Ferdinand, Meister, Toni Luise, Vollmer, Tanja, Fischer, Bastian, Steinmann, Jörg, Krawczyk, Adalbert, V’kovski, Philip, Todt, Daniel, Steinmann, Eike, Pfaender, Stephanie, Zimmer, Gert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563800/ https://www.ncbi.nlm.nih.gov/pubmed/32679691 http://dx.doi.org/10.3390/vaccines8030386 |
Ejemplares similares
-
Temperature-dependent surface stability of SARS-CoV-2
por: Kratzel, Annika, et al.
Publicado: (2020) -
Quantification of Lyssavirus-Neutralizing Antibodies Using Vesicular Stomatitis Virus Pseudotype Particles
por: Moeschler, Sarah, et al.
Publicado: (2016) -
Antiviral Effect of Budesonide against SARS-CoV-2
por: Heinen, Natalie, et al.
Publicado: (2021) -
No Evidence for Human Monocyte-Derived Macrophage Infection and Antibody-Mediated Enhancement of SARS-CoV-2 Infection
por: García-Nicolás, Obdulio, et al.
Publicado: (2021) -
Immunogenicity of propagation-restricted vesicular stomatitis virus encoding Ebola virus glycoprotein in guinea pigs
por: Locher, Samira, et al.
Publicado: (2018)